- Home
- PLUG vs IRON Comparison
PLUG vs IRON Comparison
Compare PLUG & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- IRON
- Stock Information
- Founded
- PLUG 1997
- IRON 2017
- Country
- PLUG United States
- IRON United States
- Employees
- PLUG N/A
- IRON N/A
- Industry
- PLUG Industrial Machinery/Components
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- PLUG Energy
- IRON Health Care
- Exchange
- PLUG Nasdaq
- IRON Nasdaq
- Market Cap
- PLUG 1.8B
- IRON 1.9B
- IPO Year
- PLUG 1999
- IRON N/A
- Fundamental
- Price
- PLUG $2.44
- IRON $58.25
- Analyst Decision
- PLUG Hold
- IRON Strong Buy
- Analyst Count
- PLUG 21
- IRON 10
- Target Price
- PLUG $3.85
- IRON $73.70
- AVG Volume (30 Days)
- PLUG 69.6M
- IRON 267.1K
- Earning Date
- PLUG 02-28-2025
- IRON 11-12-2024
- Dividend Yield
- PLUG N/A
- IRON N/A
- EPS Growth
- PLUG N/A
- IRON N/A
- EPS
- PLUG N/A
- IRON N/A
- Revenue
- PLUG $659,505,000.00
- IRON N/A
- Revenue This Year
- PLUG N/A
- IRON N/A
- Revenue Next Year
- PLUG $27.18
- IRON N/A
- P/E Ratio
- PLUG N/A
- IRON N/A
- Revenue Growth
- PLUG N/A
- IRON N/A
- 52 Week Low
- PLUG $1.60
- IRON $25.60
- 52 Week High
- PLUG $5.14
- IRON $77.60
- Technical
- Relative Strength Index (RSI)
- PLUG 47.83
- IRON 40.61
- Support Level
- PLUG $2.55
- IRON $57.09
- Resistance Level
- PLUG $2.97
- IRON $61.08
- Average True Range (ATR)
- PLUG 0.32
- IRON 2.83
- MACD
- PLUG -0.02
- IRON -0.58
- Stochastic Oscillator
- PLUG 26.67
- IRON 14.04
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem-from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.